Back to search

Article

Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation

2024-04-17

Abstract excerpt

<h4>Background</h4> LRRK2-targeting therapeutics that inhibit LRRK2 kinase activity have advanced to clinical trials in idiopathic Parkinson’s disease (iPD). LRRK2 phosphorylates Rab10 on endolysosomes in phagocytic cells to promote some types of immunological responses. The identification of factors that regulate LRRK2-mediated Rab10 phosphorylation in iPD, and whether phosphorylated-Rab10 levels change in diffe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c124422c-0d5f-5f83-963e-ab585afcac83
DOI
10.1101/2024.04.15.589570
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammationDOI 10.1101/2024.04.15.589570
Select a neighboring publication to make it the new centre.